The FY2025 (Dec) proxy of Cytek Biosciences names 16 peer companies for pay. Among Cytek Biosciences and these peers, CEO pay was 8th highest of 9 and total shareholder return was 6th highest of 9.
8th highest of 9in Cytek Biosciences and its pay peers, FY2025 (Dec) by CEO pay:
$4.3M$13.8M
6th highest of 9in Cytek Biosciences and its pay peers, FY2025 (Dec) by total shareholder return:
$7$86
Pay peer group, FY2025 (Dec) proxy
| Twist Bioscience | ||
| AtriCure | ||
| Adaptive Biotechnologies | ||
| Standard Biotools | ||
| Veracyte | ||
| 10x Genomics | ||
| Angiodynamics | ||
| Pacific Biosciences Of California | ||
| Axonics, Inc. | Not disclosed | Not disclosed |
| BioLife Solutions, Inc. | Not disclosed | Not disclosed |
| Codexis, Inc. | Not disclosed | Not disclosed |
| Harvard Bioscience, Inc. | Not disclosed | Not disclosed |
| Mesa Laboratories Inc /Co/ | Not disclosed | Not disclosed |
| Nevro Corp. | Not disclosed | Not disclosed |
| Quanterix | Not disclosed | Not disclosed |
| Surmodics, Inc. | Not disclosed | Not disclosed |
16 companies
Changes by year
No proxy on file names a change to the peer group.
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.